Today

Agents

Chat

Arena

Discover

More

App

Tenax Therapeutics' heart drug misses main goal in late-stage study - TENX News | Rallies

Tenax Therapeutics' heart drug misses main goal in late-stage study

TENX•2026-08-10

Late-stage study misses primary endpoint

Aug 10 (Reuters) - Tenax Therapeutics TENX.O said on Monday its experimental heart drug failed to meet the main goal of a late-stage study.

Related News

Canada's Barrick misses profit estimates as gold costs rise, strikes deal with Newmont

GOLD•2026-08-10

Founder Group wins RM 4.7 million contract for 1.4 MW rooftop solar at Terengganu shrimp farm

FGL•2026-08-10

Beazer Homes USA, Inc. <BZH.N>: Oppenheimer cuts to perform from outperform

BZH•2026-08-10

DataMeds AI rebrands pharmacy units as Corexa Pharmacy, Corexa Tech & Hub under Corexa Health division

MEDS•2026-08-10

Tenax heart drug fails to improve walking results in study, shares plunge

TENX•2026-08-10